Skip to content

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2010-020919-37-BE
Enrollment
Unknown
Registered
2010-10-12
Start date
2010-11-19
Completion date
Unknown
Last updated
2014-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post operative pain after total knee replacement MedDRA version: 12.1 Level: LLT Classification code 10036236 Term: Postoperative pain relief

Interventions

Trade Name: oxyContin Pharmaceutical Form: Tablet INN or Proposed INN: OXYCODONE CAS Number: 76426 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 5-10

Sponsors

University Hospitals Leuven
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patient of at least 18 years or older who are sheduled for a total knee prosthesis Are the trial subjects under 18? Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: A history of hypersensitivity to oxycodone, patients receiving opiod substitution therapy for opioid addiction patients receiving opioid treatment for chronic pain or cancer pain before surgery.

Design outcomes

Primary

MeasureTime frame
Main Objective: To evaluate the analgesic efficacy of oxycodone;Secondary Objective: to asses adverse events;Primary end point(s): The absolute change at postoperative day 8 from baseline (ie postoperative day 1) of the average daily NRS score.

Countries

Belgium

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026